{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:29:47Z","timestamp":1794266987442,"version":"4.9.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijpharm.2018.09.014","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T23:47:53Z","timestamp":1537487273000},"page":"486-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The respiratory delivery of high dose dry powders"],"prefix":"10.1016","volume":"550","author":[{"given":"Shyamal C","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian G","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.09.014_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijpharm.2018.05.036","article-title":"Formulation techniques for high dose dry powders","volume":"547","author":"Brunaugh","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.05.011","article-title":"Application of an inline dry powder inhaler to deliver high dose pharmaceutical aerosols during low flow nasal cannula therapy","volume":"546","author":"Farkas","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2018.06.006","article-title":"Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapy","volume":"548","author":"Buttini","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijpharm.2018.07.008","article-title":"Challenges for pulmonary delivery of high powder doses","volume":"548","author":"Sibum","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijpharm.2018.07.050","article-title":"Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs","volume":"549","author":"Hatipoglu","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2018.08.061","article-title":"High dose dry powder inhalers to overcome the challenges of tuberculosis treatment","author":"Momin","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2018.07.065","article-title":"Carrier free versus carrier formulations of spray dried indomethacin microparticles for dry powder inhalation","volume":"549","author":"Ceschan","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijpharm.2018.04.034","article-title":"Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation","volume":"544","author":"Shetty","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijpharm.2018.07.011","article-title":"Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment","volume":"548","author":"Khadka","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2018.05.065","article-title":"Preparation and optimization of a dry powder for inhalation of second-line anti-tuberculosis drugs","volume":"547","author":"Ranjan","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2018.06.038","article-title":"DPI formulations for high dose applications - challenges and opportunities","volume":"548","author":"Scherlie\u00df","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2018.07.054","article-title":"Dosing considerations for inhaled biologics","volume":"549","author":"Ferrati","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ijpharm.2018.07.007","article-title":"Dosing strategies in respiratory therapies","volume":"548","author":"Yeung","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.014_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2018.04.012","article-title":"Limitations of high dose carrier based formulations","volume":"544","author":"Yeung","year":"2018","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318306653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318306653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:39:27Z","timestamp":1759916367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318306653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":14,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0378517318306653"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.09.014","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The respiratory delivery of high dose dry powders","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}